Transforming Regulatory Affairs into Enterprise Intelligence
Regulatory updates is a continuous, enterprise-wide challenge. In highly regulated industries such as life sciences, organizations must rapidly interpret evolving requirements and act across products, markets and functions.
However, many regulatory operations are still burdened by fragmented systems, manual effort and limited scalability. Teams often spend significant time monitoring updates, comparing guidelines, assessing impact and coordinating responses—slowing execution and increasing regulatory risk.
HCLTech Intelligent Regulatory Platform (IRP) is built to change that, driving faster regulatory action, sharper decision-making and enterprise-wide clarity, powered by AI-driven speed to insight.
AI-Driven Intelligence Platform for Global Regulatory Affairs
IRP transforms regulatory affairs into an enterprise-wide intelligence capability. Designed for Life Sciences organizations, it delivers AI-powered decisions that are transparent, traceable and fully auditable across the global regulatory landscape.
Customized for the life sciences industry, IRP's features include:
- Regulation-first design with complete auditability
- Continuous monitoring of 350+ health authorities worldwide
- Agentic AI orchestration across end-to-end regulatory workflows
- Human-in-the-loop oversight to ensure trust and control
Driving Measurable Impact for Our Clients
These are real outcomes achieved by life sciences organizations using our IRP solution across their operations.
Less manual monitoring
Lower guidelines comparison effort
Reduced labeling update cycle time
Lower regulatory risk and omissions
Higher competitive awareness
Accelerated speed to market
A Fully Customizable Industry Regulatory Platform
An AI-powered command center for global regulatory updates
Stay ahead of change with autonomous, real-time intelligence on updates from the FDA, EMA, MHRA, WHO and 350+ global health authorities. The platform helps teams respond faster to regulatory updates, labeling changes and emerging competitive signals.
- 32%-40% reduced manual effort in global regulatory monitoring
- Supports proactive submissions and market access decisions
- Consolidated intelligence feed with role-based alerts
- Zero-latency update detection across global sources
Autonomous guideline comparison with no blind spots
Reduce risks and accelerate response with AI-powered comparison of evolving global guidelines. The platform automatically identifies changes, conflicts and impact areas across regulatory frameworks to support alignment with the FDA, EMA and other health authorities.
- Deep semantic comparison against internal frameworks
- ~40% reduction in manual comparison effort
- Instant impact scoring across the product portfolio
Real-time visibility into the competitive landscape
Strengthen portfolio and market strategy with actionable intelligence on competitor filings, clinical developments, product updates and market movements. The platform equips R&D, regulatory, quality and commercial teams with timely insights to make faster, better-informed decisions.
- 2–3x enhanced competitive intelligence coverage
- Cross-functional insights beyond regulatory updates
- Market movement signals aligned to regulatory events
The world’s first fully synchronized, AI-driven labeling platform
Improve labeling management capability by automating the creation, updating and synchronization of product labels from SmPCs and PILs to target labels, IFUs and CCDS-to-local labels.
- 35%-40% reduced labeling update cycle time
- Minimizes errors and ensures cross-market consistency
- Full audit trail on every label version and change
Executive Commitment

Chief Growth Officer and Global Head, Life Sciences and Healthcare Industries, HCLTech
“Regulatory complexity is increasingly shaping how quickly life sciences organizations can bring new therapies and innovations to market. The Intelligent Regulatory Platform (IRP) helps enterprises navigate evolving regulatory requirements with greater speed, visibility and confidence by transforming fragmented regulations and guidance into actionable insights. Powered by GenAI and agentic workflows, IRP accelerates regulatory impact assessments and response execution, helping organizations reduce delays, strengthen regulatory readiness and support faster product approvals. In a highly competitive and tightly regulated environment, IRP enables regulatory operations to become a catalyst for innovation, growth and improved patient outcomes.”

Chief Technology Officer and Head of Ecosystems, HCLTech
“The Intelligent Regulatory Platform (IRP) enables Life Sciences enterprises to navigate global regulatory change with greater speed, confidence and precision. It transforms fragmented regulations, health authority guidance and market-level compliance obligations into actionable business insights. Leveraging GenAI and agentic workflows, IRP automates the monitoring, interpretation, impact assessment and execution of regulatory responses across the enterprise. This helps organizations accelerate decision-making, reduce the risk of delayed compliance and regulatory penalties, strengthen audit readiness and scale regulatory operations without proportional increases in cost or effort. For Life Sciences organizations, IRP is aimed at transforming regulatory affairs from a reactive compliance function into a strategic advantage.”
Recognitions
Rated Leader in the HFS Research Horizons Generative Enterprise Services 2025 report (Horizon 3)
Learn moreRated No. 1 in ISG Client Experience scores for Generative AI Services for two consecutive years
Learn moreHCLTech recognized as a Leader in Everest Group’s Healthcare Data, Analytics and AI Services PEAK Matrix® Assessment 2025
Learn moreHCLTech recognized as a Leader in Everest Group’s Life Sciences Digital Services PEAK Matrix® Assessment 2025
Learn more















































Resources
Kanda Natarajan, VP of IT at GSK, and Vijay Guntur, CTO and Head of Ecosystems at HCLTech, join Sophia Zhang, SVP at Conde Nast to reflect on their experiences and highlight key lessons for leaders.
IRP is an Agentic AI platform that unifies regulatory operations into one connected ecosystem-boosting efficiency and reducing manual work for regulatory teams.
PubMed article summarization tool at a North American Pharmaceutical Company
Global life sciences leader achieves ~30% faster authoring with GenAI
Moving beyond projects to products: Transforming IT models in life sciences and healthcare
Global AI Conversations
IRP has been showcased at leading global forums where industry leaders explore the future of AI and digital transformation.
Glimpses of IRP in Action









Interested in IRP for your organization?
Turn regulatory change into intelligence. Explore how HCLTech IRP uses AI, real-time monitoring and automated workflows to accelerate compliance decisions across life sciences.

Frequently Asked Questions about Regulatory Affairs
A regulatory intelligence platform is an AI-driven system that continuously monitors regulatory updates posted by global health authorities, consolidates regulatory changes and automates impact assessment across your product portfolio. HCLTech IRP transforms fragmented manual processes into a unified, enterprise-wide intelligence capability powered by GenAI and Agentic AI.
IRP uses autonomous agents to perform continuous multi-site crawling of global health authority websites including FDA, EMA, MHRA and WHO. All updates are consolidated into a unified regulatory intelligence feed, with role-based alerts dispatched to relevant stakeholders the moment a meaningful change is detected.
IRP automates regulatory workflows through Agentic AI that detects updates, assesses impact, triggers role-based alerts, initiates document authoring and propagates changes across global labeling and regulatory submissions—all within a single integrated platform, reducing manual intervention by 32%-40%.
Key benefits include: 32%-40% reduction in manual regulatory monitoring effort, 35%-40% reduction in labeling update cycle time, 28%-38% reduction in regulatory risk and omissions, 2-3x enhanced competitive intelligence and significantly improved audit readiness. Platforms like IRP also enable faster market access decisions and stronger cross-functional alignment.
Yes. IRP monitors and consolidates updates from 350+ global health authorities including FDA, EMA, MHRA and WHO into a unified regulatory intelligence feed, enabling multi-region tracking, cross-market impact assessment and globally synchronized labeling from a single platform.
AI improves regulatory operations by autonomously monitoring 350+ global health authority regulatory updates, instantly comparing new regulations against internal frameworks, identifying impacted products and generating audit-ready documentation. This eliminates blind spots, reduces human error and ensures your teams act on regulatory signals before they become risks and delays to market.
Regulatory impact assessment is a structured evaluation that determines how a new or updated regulation affects an organization's operations, risks and compliance obligations. IRP automates this using deep semantic AI, instantly mapping regulatory changes to affected products, markets and documentation—providing actionable impact scores within minutes.
AI enables proactive regulatory lifecycle management by continuously monitoring health authority updates, intelligently prioritizing regulatory changes, automating compliant document authoring, synchronizing labeling across systems and providing real-time competitive insights—accelerating submissions, reducing risk and improving accuracy across the full lifecycle.
IRP supports custom integration with existing third-party applications through tailored workflows, APIs and data exchange mechanisms. Where direct integration is not optimal, IRP can also be rebuilt on your preferred platform via professional services—maintaining core IRP functionality while leveraging your native system capabilities.
IRP ensures complete audit readiness by maintaining traceable, timestamped records of every regulatory change, impact decision and document update. All modules align with global health authority guidelines and embed explainable AI with human oversight—making every decision transparent and defensible during regulatory inspections.

